Please use this identifier to cite or link to this item:
Title: Neutrophil Lymphocyte Ratio and Cardiovascular Disease Risk: A Systematic Review and Meta-Analysis
Authors: Angkananard T.
Anothaisintawee T.
McEvoy M.
Attia J.
Thakkinstian A.
Keywords: acute coronary syndrome
cardiovascular disease
cardiovascular risk
cerebrovascular accident
clinical outcome
coronary artery disease
disease association
neutrophil lymphocyte ratio
systematic review
cardiovascular disease
meta analysis
odds ratio
risk factor
treatment outcome
Cardiovascular Diseases
Odds Ratio
Publication Bias
Risk Factors
Treatment Outcome
Issue Date: 2018
Abstract: Objective. This systematic review aimed to measure the association between neutrophil lymphocyte ratio (NLR) and cardiovascular disease (CVD) risk. Methods. Relevant studies were identified from Medline and Scopus databases. Observational studies with NLR as a study factor were eligible for review. The outcomes of interest were any type of CVD including acute coronary syndrome, coronary artery disease, stroke, or a composite of these cardiovascular events. Mean differences in NLR between CVD and non-CVD patients were pooled using unstandardized mean difference (USMD). Odds ratios of CVD between high and low NLR groups were pooled using a random effects model. Results. Thirty-eight studies (n=76,002) were included. High NLR was significantly associated with the risks of CAD, ACS, stroke, and composite cardiovascular events with pooled ORs of 1.62 (95% CI: 1.38-1.91), 1.64 (95% CI: 1.30, 2.05), 2.36 (95% CI: 1.44, 2.89), and 3.86 (95% CI: 1.73, 8.64), respectively. In addition, mean NLRs in CAD, ACS, and stroke patients were significantly higher than in control groups. Conclusion. High NLR was associated with CAD, ACS, stroke, and composite cardiovascular events. Therefore, NLR may be a useful CVD biomarker. © 2018 Teeranan Angkananard et al.
ISSN: 23146133
Appears in Collections:Scopus 1983-2021

Files in This Item:
There are no files associated with this item.

Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.